Perbandingan Kadar Glukosa Darah Sewaktu Pada Kehamilan Normal Dan Kehamilan Dengan Preeklampsia Berat

Authors

  • Elsa Octavia Teknologi Laboratorium Medis, Poltekkes Kemenkes Jakarta III
  • Tri Prasetyorini Teknologi Laboratorium Medis, Poltekkes Kemenkes Jakarta III
  • Nova Hardianto Teknologi Laboratorium Medis, Poltekkes Kemenkes Jakarta III

Keywords:

preeklampsia berat, kehamilan, glukosa darah sewaktu, diabetes melitus

Abstract

Preeklampsia berat merupakan salah satu faktor yang meningkatkan risiko morbiditas dan mortalitas baik pada ibu hamil maupun janin yang dikandungnya. Hubungan antara status glukosa darah dengan preeklampsia menjadi topik penting yang terus diteliti dan dikaji agar dapat memahami, mencegah, dan mengendalikan preeklampsia pada ibu hamil. Penelitian ini bertujuan untuk mengetahui perbandingan kadar glukosa darah sewaktu (GDS) antara ibu hamil normal dan ibu hamil dengan preeklampsia berat (PEB). Penelitian ini menggunakan desain observasional potong lintang dengan fokus analisis komparatif dua kelompok tidak berpasangan. Subyek penelitian terdiri dari 35 orang ibu hamil normal dan 35 orang ibu hamil dengan PEB yang melakukan pemeriksaan kesehatan di RS Budi Kemuliaan, Jakarta. Hasilnya menunjukan bahwa kelompok ibu dengan kehamilan normal memiliki kadar GDS dengan rata-rata 91 ± 13 mg/dL dan nilai tengah 91 (64—119) mg/dL, sedangkan kelompok ibu dengan kehamilan PEB memiliki kadar GDS dengan rata-rata 104 ± 48 mg/dL dan nilai tengah 93 (69—357) mg/dL. Hasil uji Mann-Whitney menunjukan nilai p = 0,321 (nilai p > 0,05). Dengan demikian, tidak terdapat perbedaan kadar GDS yang signifikan secara statistik antara kelompok ibu dengan kehamilan normal dan ibu dengan kehamilan PEB. Pada penelitian selanjutnya, disarankan menggunakan rancangan kohor atau kasus kontrol agar dapat menguji hubungan kausalitasnya serta penggunaan tes toleransi glukosa oral.

References

Alanazi, A. S., Victor, F., Rehman, K., Khan, Y. H., Yunusa, I., Alzarea, A. I., & Mallhi, T. H. (2022). Pre-existing diabetes mellitus, hypertension, and kidney disease as risk factors of pre-eclampsia: A disease of theories and its association with genetic polymorphism. *International Journal of Environmental Research and Public Health, 19*(24), 16690. https://doi.org/10.3390/ijerph192416690

Anonim, T., Harnany, A. S., & Supriyo, S. (2020). Pengaruh LDL dan diabetes melitus terhadap kejadian preeklampsi kehamilan. *Jurnal Lintas Keperawatan, 1*(1), 1–7. https://doi.org/10.31983/jlk.v1i1.6453

Aziz, F., Khan, M. F., & Moiz, A. (2024). Gestational diabetes mellitus, hypertension, and dyslipidemia as the risk factors of preeclampsia. *Scientific Reports, 14*(1), 6182. https://doi.org/10.1038/s41598-024-56790-z

Bittner, J. M. P., Gilman, S. E., Zhang, C., Chen, Z., & Cheon, B. K. (2023). Relationships between early-life family poverty and relative socioeconomic status with gestational diabetes, preeclampsia, and hypertensive disorders of pregnancy later in life. *Annals of Epidemiology, 86*, 8–15. https://doi.org/10.1016/j.annepidem.2023.08.002

Bolatai, A., He, Y., & Wu, N. (2022). Vascular endothelial growth factor and its receptors regulation in gestational diabetes mellitus and eclampsia. *Journal of Translational Medicine, 20*(1), 400. https://doi.org/10.1186/s12967-022-03603-4

Cresswell, J. A., Alexander, M., Chong, M. Y. C., Link, H. M., Pejchinovska, M., Gazeley, U., & Say, L. (2025). Global and regional causes of maternal deaths 2009–20: A WHO systematic analysis. *The Lancet Global Health, 13*(4), e626–e634. https://doi.org/10.1016/S2214-109X(24)00560-6

Eberle, C., & Stichling, S. (2022). Environmental health influences in pregnancy and risk of gestational diabetes mellitus: A systematic review. *BMC Public Health, 22*(1), 1572. https://doi.org/10.1186/s12889-022-13965-5

Englund Ögge, L., Dotevall, A., Elfvin, A., Sandgren, U., Linden, K., Bohlin, L., & Hagman, A. (2024). Glycemic control assessed by continuous glucose monitoring during pregnancy in women with type 1 diabetes and its association with preeclampsia: An observational Swedish cohort study. *Acta Obstetricia et Gynecologica Scandinavica, 103*(7), 1426–1436. https://doi.org/10.1111/aogs.14856

Guida, J. P. de S., Andrade, B. G. de, Pissinatti, L. G. F., Rodrigues, B. F., Hartman, C. A., & Costa, M. L. (2022). Prevalence of preeclampsia in Brazil: An integrative review. *Revista Brasileira de Ginecologia e Obstetrícia, 44*(7), 686–691. https://doi.org/10.1055/s-0042-1742680

Hansel Wijaya, N. R., & Susanto, R. (2023). Prevalensi preeklampsia dan bayi berat lahir rendah di Rumah Sakit X Jakarta tahun 2019–2020. *Prepotif: Jurnal Kesehatan Masyarakat, 6*(2), 1866–1870. https://doi.org/10.31004/prepotif.v6i2.5531

He, L., Lu, L., Zhang, X., Wu, X., Zhan, F., & Wu, J. (2025). Cross-talk between mitophagy pathways in pre-eclampsia and gestational diabetes mellitus: A systematic analysis of shared molecular mechanisms. *European Journal of Medical Research, 30*(1), 568. https://doi.org/10.1186/s40001-025-02823-w

Hegazy, A., Eid, F. A., Ennab, F., Sverrisdóttir, Y. B., Atiomo, W., & Azar, A. J. (2024). Prevalence of pre-eclampsia in women in the Middle East: A scoping review. *Frontiers in Public Health, 12*. https://doi.org/10.3389/fpubh.2024.1384964

Kinshella, M.-L. W., Pickerill, K., Prasad, S., Campbell, O., Devji, J., Lopes, L. V., & the PRE-EMPT Network. (2025). Towards the development of a conceptual framework of the determinants of pre-eclampsia: A hierarchical systematic review of social determinants. *BJOG: An International Journal of Obstetrics & Gynaecology*. Advance online publication. https://doi.org/10.1111/1471-0528.18082

Kumar, A., Vanamail, P., Gupta, R. K., & Husain, S. A. (2023). Prediction of pre-eclampsia in diabetic pregnant women. *Indian Journal of Medical Research, 157*(4), 330–344. https://doi.org/10.4103/ijmr.IJMR_1594_19

Langi, Y. A., Waspadji, S., Eliana, F., Purnamasari, D., Novida, H., Adam, F. M., & Septina, L. (2021). *Pedoman diagnosis dan penatalaksanaan hiperglikemia dalam kehamilan 2021*. Perkumpulan Endokrinologi Indonesia. https://pbperkeni.or.id/unduhan

Lee, J., Ouh, Y., Ahn, K. H., Hong, S. C., Oh, M.-J., Kim, H.-J., & Cho, G. J. (2017). Preeclampsia: A risk factor for gestational diabetes mellitus in subsequent pregnancy. *PLOS ONE, 12*(5), e0178150. https://doi.org/10.1371/journal.pone.0178150

Li, H., Yin, B., Jiang, N., & Zhu, B. (2025). Effect of combined gestational diabetes mellitus and preeclampsia on pregnancy outcomes. *Clinical and Experimental Obstetrics & Gynecology, 52*(2). https://doi.org/10.31083/CEOG27065

Li, Q., Yan, J., Zhao, C., Li, M., Gu, Y., Wang, B., & Yue, C. (2025). Association of metabolic score for insulin resistance and preeclampsia: A multicenter cohort study. *Lipids in Health and Disease, 24*(1), 323. https://doi.org/10.1186/s12944-025-02705-4

Li, Q., Zhao, C., Liu, M., Li, M., Zhang, Y., & Yue, C. (2025). Association between triglyceride-glucose index in early pregnancy and risk of preeclampsia: A multicenter retrospective cohort study. *Lipids in Health and Disease, 24*(1), 152. https://doi.org/10.1186/s12944-025-02556-z

Pearson, M. C., Wang, H., Murdoch, C. E., & Doney, A. S. F. (2025). Clinical implications of a history of pre-eclampsia in women with type 2 diabetes mellitus. *Diabetic Medicine, 42*(6), e70046. https://doi.org/10.1111/dme.70046

Perkumpulan Endokrinologi Indonesia. (2024). *Pedoman pengelolaan dan pencegahan diabetes melitus tipe 2 di Indonesia 2024*. https://pbperkeni.or.id/unduhan

Sinkey, R. G., Battarbee, A. N., Bello, N. A., Ives, C. W., Oparil, S., & Tita, A. T. N. (2020). Prevention, diagnosis, and management of hypertensive disorders of pregnancy: A comparison of international guidelines. *Current Hypertension Reports, 22*(9), 66. https://doi.org/10.1007/s11906-020-01082-w

Torres-Torres, J., Espino-y-Sosa, S., Martinez-Portilla, R., Borboa-Olivares, H., Estrada-Gutierrez, G., Acevedo-Gallegos, S., & Rojas-Zepeda, L. (2024). A narrative review on the pathophysiology of preeclampsia. *International Journal of Molecular Sciences, 25*(14), 7569. https://doi.org/10.3390/ijms25147569

Trivett, C., Lees, Z. J., & Freeman, D. J. (2021). Adipose tissue function in healthy pregnancy, gestational diabetes mellitus and pre-eclampsia. *European Journal of Clinical Nutrition, 75*(12), 1745–1756. https://doi.org/10.1038/s41430-021-00948-9

Vera-Ponce, V. J., Loayza-Castro, J. A., Ballena-Caicedo, J., Valladolid-Sandoval, L. A. M., Zuzunaga-Montoya, F. E., & Gutierrez De Carrillo, C. I. (2025). Global prevalence of preeclampsia, eclampsia, and HELLP syndrome: A systematic review and meta-analysis. *Frontiers in Reproductive Health, 7*. https://doi.org/10.3389/frph.2025.1706009

Vito, D. M., Amansyah, A., & Meldawati. (2022). Hubungan kadar gula darah dan indeks massa tubuh terhadap kejadian preeklamsia-eklamsia. *Jurnal Pendidikan dan Konseling, 4*(5), 6498–6504. https://doi.org/10.31004/jpdk.v4i5.7745

Wibowo, N., Irwinda, R., Frisdiantiny, E., Karkata, M. K., Mose, J. C., Chalid, M. T., & Gumilar, E. (2016). *Pedoman nasional pelayanan kedokteran diagnosis dan tata laksana pre-eklampsia*. Perkumpulan Obstetri dan Ginekologi Indonesia.

World Health Organization. (2025). *Pre-eclampsia*. Retrieved November 25, 2025, from https://www.who.int/news-room/fact-sheets/detail/pre-eclampsia

Yang, Y., Le Ray, I., Zhu, J., Zhang, J., Hua, J., & Reilly, M. (2021). Preeclampsia prevalence, risk factors, and pregnancy outcomes in Sweden and China. *JAMA Network Open, 4*(5), e218401. https://doi.org/10.1001/jamanetworkopen.2021.8401

Ye, Y., Zhang, L., Han, Y., & Yu, X. (2025). Prevalence and risk factors of preeclampsia in pregnant women with gestational diabetes mellitus. *British Journal of Hospital Medicine, 86*(6), 1–13. https://doi.org/10.12968/hmed.2024.0990

Published

28-05-2026